LEP and myeloid sarcoma: Circulating levels of visfatin/NAMPT in RR-MS patients was significantly higher compared those in two other subtypes, whereas, serum leptin levels were significantly decrease in RR-MS patients as compared to SP-MS and PP-MS patients.